Increased incidence of preeclampsia in pregnancies complicated by fetal malformation

Gynecologic and Obstetric Investigation

Volumn 44, Issue 2, 1997, Pages 107-111

  Vesce, Fortunato ^a   Farina, Antonio ^a   Giorgetti, Maria ^a   Jorizzo, Gianfranco ^a   Bianciotto, Andrea ^a   Calabrese, Olga ^b   Mollica, Gioacchino ^a  

^a Section of Obstetrics and Gynecology   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

Author keywords

Angiogenesis; Fetal malformations; Hypospadia; Placental vasculopathy; Preeclampsia

Indexed keywords

ARTICLE; FETUS; FETUS MALFORMATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MALE GENITAL TRACT MALFORMATION; MULTIVARIATE ANALYSIS; NEWBORN; PREECLAMPSIA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 0030931953     PISSN: 03787346     EISSN: 1423002X     Source Type: Journal    
DOI: 10.1159/000291497     Document Type: Article

References (38)

1. De Watteville H: Fetal malformation and toxemia; in Hammond J, Browne FJ, Wolsten-holme GW (eds): Toxemia of Pregnancy, Human and Veterinary. London, Churchill, 1950. pp 202-209.
2. Nelson TR: A clinical study of pre-eclampsia. J Obstet Gynaecol Brit Emp 1955;62:48-51.
3. Clinch J: Does anencephaly cause pre-eclampsia? J Irish Med Assoc 1980;73:350-354.
4. MacGillivray I: Pre-Eclampsia, The Hypertensive Disease of Pregnancy. London, Saunders, 1983, p 188.
5. Wallenburg HCS: Changes in the coagulation system and platelets in pregnancy-induced hypertension and pre-eclampsia: in Sharp F, Symmonds EM (eds): Hypertension in Pregnancy. Ithaca, Perinatology Press, 1986, pp 227-248.
6. Dekker GA, Dc Vries JIP, Doelitzsch PM. Huijgens PC, Von Blomberg BME, Jakobs C, Van Geijn HP: Underlying disorders associated with severe early-onsct of pre-eclampsia. Am J Obstet Gynecol 1995:173:1042-1048.
7. Romero R. Lockwood C, Oyarzun E, Hobbins JC: Toxemia: new concepts in an old disease. Semin Perinatol 1988;4:302-323.
8. Newman RB, Eddy GL: Association of eclampsia and hydatidiform mole: Case report and review of the literature. Obstet Gynecol Surv 1988;43:185-190.
9. Slattery MA, Khong Y. Dawkins RR. Pridmore BR, Hague WM: Eclampsia in association with partial molar pregnancy and congenital abnormalities. Am J Obstet Gynecol 1993:169: 1625-1627.
10. Graves SW, Seely EW, Williams GH: Genes, phenotypes and hypertensive pregnancies. Nature Gen 1993;4:7-8.
11. Brambati B, Simoni G, Travi M, Dancsino C, Tului L, Privitera O, Stioui S. Tedeschi S, Russo S, Primignani P: Genetic diagnosis by chorionic villus sampling before 8 gestational weeks: Efficiency, reliability, and risks on 317 completed pregnancies. Prenat Diagn 1992;2: 789-799.
12. Mastroiacovo P, Botto LD, Cavalcanti DP, Lalatta F, Selicomi A, Tozzi AE, Baronciani D, Cigolotti AC, Giordano S, Petroni F, et al: Limb anomalies following chorionic villus sampling: A registry based case-control study. Am J Med Genet 1992:44:856-864.
13. Mastroiacovo P, Tozzi AE, Agosti S, Bocchino G, Bovicelli L, Dalpra L. Carbone LD. Lituan-ia M, Luttichau A, Mantcgazza F, et al: Transverse limb reduction defects after chorion villus sampling: a retrospective cohort study. Prenat Diagn 1993;13:1051-1056.
14. Blakemore K, Filkins K. Luthy DA, Platt LD. Medearis AL, Carlson D, Priest J, Korotkin J. Vcrp MS, Padilla LM, et al: Cook obstetrics and gynecology catheter multicenter chorionic villus sampling trial: Comparison of birth defects with expected rates. Am J Obstet Gynecol 1993;169:1022-1026.
15. Firth HV, Boyd PA, Chamberlain PF, Mackenzie IZ. Morrisskay GM. Huson SM: Analysis of limb reduction defects in babies exposed to chorionic villus sampling. Lancet 1994:343: 1069-1071.
16. Olncy RS, Khoury MJ, Alo CJ, Costa P, Edmonds LD, Flood TJ, Harris JA, Howe HL, Moore CA, Olsen CL, et al: Increased risk for transverse digital deficiency after chorionic villus sampling: Results of the United States Multistate Case-Control Study, 1988-1992. Teratology 1995;51:20-29.
17. Kuliev A, Jackson L, Froster U, Brambati B. Simpson JL, Verlinsky Y, Ginsberg N. Smidt-Jenscn S, Zakut H: Choronic villus sampling safety. Report of World Health Organization/ EURO Meeting in Association with the 7 International Conference on Early Prenatal Diagnosis of Genetic Disease, Tel-Aviv, Israel, May 21, 1994. Am J Obstet Gynecol 1996; 174:807-811.
18. Froster UG, Jackson L: Limb defects and chorionic villus sampling: results from an international registry, 1992-1994. Lancet 1996:347: 489-494.
19. Quintero RA, Romero R, Mahoney MJ, Abu-hamad A, Vecchio M, Holden J, Hobbins JC: Embryoscopic demonstration of hemorrhagic lesions on the human embryo after placental trauma. Am J Obstet Gynecol 1993; 168:756-759.
20. Webster WS. Lipson AH, Brown-Woodman PDC: Uterine trauma and limb defects. Teratology 1987;35:253-260.
21. D'Amato RY, Loughnan MS, Flynn E. Folk-man Y: Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA 1994:91: 4082-4085.
22. Vesce F, Farina A, Jorizzo G, Tarabbia C, Calabrese O, Pelizzola D. Giovannini G, PilTanel-li A: Raised levels of amniotic endothelin in pregnancies with fetal aneuploidies. Fetal Diagn Ther 1996; 11:94-98.
23. ISTAT Istituto Centrale di Statistica: Classificazione delle malattie, traumatismi e cause di morte. 9 revisione, Gazzetta Ufficiale. Roma, Tipografia dello Stato, 1975.
24. Redman CWG: The definition of pre-cclamp-sia. Scand J Clin Lab Invest 1984;169:7-14.
25. Redman CWG: The definition of pre-eclampsia; in Sharp F, Symmonds EM: Hypertension in Pregnancy. Proc 16th Study Group of the Royal College of Obstetricians and Gynaecologists. New York, Perinatology Press, 1986. pp 3-17.
26. Vesce F, Travagli S, Farina A, Cocilovo G: Evaluation of independent prognostic factors in pregnancy induced hypertension using a stepwise logistic regression. J Obstct Gynecology 1993;13:419-422.
27. Lazarchick J, Stubbs TM, Romein L, Van Dorstcn JP. Loadholt CB: Predictive value of fibronectin levels in normotensive gravid women destined to become pre-eclamptic. Am J Obstct Gynecol 1986; 154:1050-1052.
28. Redman CWG, Beilin LJ. Denson KWE, Bolton FG: Factor VIII consumption in preeclampsia. Lancet 1977;Vol ii: 1249.
29. Gant NF, Daley GL. Chand S, Whalley PJ. McDonald PC: A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest 1973;52:2682-2686.
30. Taylor RN, Helibron DC, Roberts JM: Growth factor activity in the blood of women in whom pre-eclampsia develops is elevated from early pregnancy. Am J Obstct Gynecol 1990,163: 1839-1844.
31. Calzolari E, Contiero MR, Roncarati E, Mat-tiuz PL, Volpato S: Aetiological factors in hypospadias. J Med Genet 1986;23:333-337.
32. Hayles AB, Nolan RB: Masculinization of the female fetus, possibly related to administration of progesterone during pregnancy. Mayo Clin Proc 1957;32:200-203.
33. Johnstone EE, Franklin RR: Assay of proges-tins for fetal virilizing properties in the mouse. Obstct Gynecol 1964;23:359-362
34. Heinoncn OP. Slone D. Monson RR. Hook EB. Shapiro S: Cardiovascular birth defects and antenatal exposure to female sex hormones. N Engl J Med 1977;296:67-70.
35. Aarskog D: Maternal progestins as a possible cause of hypospadias. N Engl J Med 1979:300: 75-78.
36. Mau G: Progestins during pregnancy and hypospadias. Teratology 1981;24:285-287.
37. Michaelis J, Michaelis H, Glück E, Koller S: Prospective study of suspected association between certain drugs administered during early pregnancy and congenital malformations. Teratology 1983;27:57-64.
38. Resseguie LJ, Hick JF, Bruen JA. Noller KL, O’Fallon WM. Kurland LT: Congenital malformations among offspring exposed in utero to progestins, Olmsted County, Minnesota, 1936-1974. Fertil Steril 1985;43:514-519.